News and Announcements
Leaf Resources and Novozymes Launch Biomass-To-Sugars Collaboration
- Published December 07, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
7th December 2016, ASX Announcement
Leaf Resources’ patented biomass pretreatment process- GLYCELL – is an innovative, high-yield route to clean, economical cellulosic sugars
Leaf Resources today announced a collaboration with Novozymes, the world’s largest producer of industrial enzymes, to further increase the yields and efficiency associated with Leaf Resources’ innovative biomass conversion technology.
GLYCELL1 is a unique combination of well-established process engineering and advanced chemistry. The GLYCELL technology operates at low temperature and pressure, and uses crude glycerin as a low cost, recyclable reagent. The process efficiently deconstructs plant biomass and produces a high-yield of high-quality, concentrated cellulose and hemicellulose sugars, which in turn enables cost competitive production of renewable chemicals.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
